The objective of this paper is to investigate survival and causes of death in a Danish lupus population.
Methods
Two hundred and fifteen SLE patients (94% Caucasians) were followed prospectively for up to 16 years. Thirty-eight patients died. Survival rate and causes of death were analysed.
Results
Overall standardized mortality ratio (SMR) was 2.2. Peak values were recorded for patients aged 20–29 (SMR 21.1). Cumulated survival rates at one, five, 10 and 15 years were 98.6%, 93.6%, 86.5% and 73.0%, respectively. The most common causes of death were cardiovascular events (32%), respiratory system disease (16%) and malignancies (13%). Deaths due to infections and active SLE were rare and predominated within the first seven years after diagnosis and before age 40, while cardiovascular deaths prevailed after 20 years’ follow-up.
Conclusion
This study shows that despite progress in lupus management, including direct access to specialized hospital care and increased use of hydroxychloroquine, mortality in lupus patients is still increased. Main causes of death were active disease and infections among the young and newly diagnosed, while cardiovascular deaths prevailed in longstanding disease.
PetriM. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol2002; 16: 847–858.
2.
BorchersATKeenCLShoenfeldYGershwinME. Surviving the butterfly and the wolf: Mortality trends in systemic lupus erythematosus. Autoimmun Rev2004; 3: 423–453.
3.
JacobsenSPetersenJUllmanS. Mortality and causes of death in 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol1999; 28: 75–81.
4.
MokCCToCHHoLYYuKL. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000–2006. J Rheumatol2008; 35: 1978–1982.
5.
UrowitzMBGladmanDDTomBDIbañezDFarewellVT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol2008; 35: 2152–2158.
6.
GustafssonJSimardJFGunnarssonI. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther2012; 14: R46–R46.
7.
AlonsoMDLlorcaJMartinez-VazquezF. Systemic lupus erythematosus in northwestern Spain: A 20-year epidemiologic study. Medicine (Baltimore)2011; 90: 350–358.
8.
DoriaAIaccarinoLGhirardelloA. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med2006; 119: 700–706.
9.
FlowerCHennisAJHambletonIRNicholsonGDLiangMH. Systemic lupus erythematosus in an Afro-Caribbean population: Incidence, clinical manifestations and survival in the Barbados National Lupus Registry. Arthritis Care Res (Hoboken)2012; 64: 1151–1158.
10.
MokCCKwokCLHoLYChanPTYipSF. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum2011; 63: 1182–1189.
11.
HellerTAhmedMSiddiqqiAWallrauchCBahlasS. Systemic lupus erythematosus in Saudi Arabia: Morbidity and mortality in a multiethnic population. Lupus2007; 16: 908–914.
12.
KangKYKwokSKJuJH. The causes of death in Korean patients with systemic lupus erythematosus over 11 years. Lupus2011; 20: 989–997.
13.
Pons-EstelGJAlarcónGSScofieldLReinlibLCooperGS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum2010; 39: 257–268.
14.
SharmaAShamannaSBKumarS. Causes of mortality among inpatients with systemic lupus erythematosus in a tertiary care hospital in North India over a 10-year period. Lupus2013; 22: 216–222.
15.
TehCLLingGR. Causes and predictors of mortality in hospitalized lupus patient in Sarawak General Hospital, Malaysia. Lupus2013; 22: 106–111.
16.
UrowitzMBBookmanAAKoehlerBEGordonDASmytheHAOgryzloMA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med1976; 60: 221–225.
17.
MossKEIoannouYSultanSMHaqIIsenbergDA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis2002; 61: 409–413.
18.
NossentJCikesNKissE. Current causes of death in systemic lupus erythematosus in Europe, 2000–2004: Relation to disease activity and damage accrual. Lupus2007; 16: 309–317.
19.
VossAGreenAJunkerP. Systemic lupus erythematosus in Denmark: Clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol1998; 27: 98–105.
20.
FriesJFHolmanHRSystemic lupus erythematosus: A clinical analysis. In: SmithLHJr (ed.) Major problems in internal medicine, Philadelphia: WB Saunders Co, 1975, pp. 1–199.
21.
TanEMCohenASFriesJF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
22.
GladmanDGinzlerEGoldsmithC. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum1996; 39: 363–369.
23.
FineJPGrayRJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc1999; 94: 496–509.
24.
LaustrupHVossAGreenAJunkerP. SLE disease patterns in a Danish population-based lupus cohort: An 8-year prospective study. Lupus2010; 19: 239–246.
25.
LaustrupHVossAGreenAJunkerP. Occurrence of systemic lupus erythematosus in a Danish community: An 8-year prospective study. Scand J Rheumatol2009; 38: 128–132.
26.
AlarcónGSRosemanJBartolucciAA. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum1998; 41: 1173–1180.
27.
LauCSYinGMokMY. Ethnic and geographical differences in systemic lupus erythematosus: An overview. Lupus2006; 15: 715–719.
28.
Stahl-HallengrenCJonsenANivedOSturfeltG. Incidence studies of systemic lupus erythematosus in Southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol2000; 27: 685–691.
29.
MoscaMTaniCAringerM. EULAR Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies. Ann Rheum Dis2009; 69: 1269–1274.
30.
BertsiasGIoannidisJPBoletisJ. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis2008; 67: 195–205.
